Medivolve Inc. (MEDVF)
OTCMKTS · Delayed Price · Currency is USD
0.0020
0.00 (0.00%)
Aug 21, 2025, 4:00 PM EDT
Medivolve Market Cap
Medivolve has a market cap or net worth of $27.00 as of August 22, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
27.00
Enterprise Value
725.99K
Revenue
666.14K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 4, 2009, Medivolve's market cap has decreased from 22.21M to 27.00, a decrease of -100.00%. That is a compound annual growth rate of -57.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 27.00 | -99.98% |
| Dec 31, 2024 | 162.12K | -44.95% |
| Dec 29, 2023 | 294.51K | -88.49% |
| Dec 30, 2022 | 2.56M | -89.25% |
| Dec 31, 2021 | 23.79M | -50.25% |
| Dec 31, 2020 | 47.82M | 1,023.43% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 398.51M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |